MA19147A1 - Derives de pyridoxine,leur procede de preparation ainsi que leur utilisation en therapeutique . - Google Patents

Derives de pyridoxine,leur procede de preparation ainsi que leur utilisation en therapeutique .

Info

Publication number
MA19147A1
MA19147A1 MA19356A MA19356A MA19147A1 MA 19147 A1 MA19147 A1 MA 19147A1 MA 19356 A MA19356 A MA 19356A MA 19356 A MA19356 A MA 19356A MA 19147 A1 MA19147 A1 MA 19147A1
Authority
MA
Morocco
Prior art keywords
pyridoxin
therapeutics
derivatives
preparation process
preparation
Prior art date
Application number
MA19356A
Other languages
English (en)
French (fr)
Inventor
Descamps M
Urbain M
Original Assignee
Labaz Sanofi Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labaz Sanofi Nv filed Critical Labaz Sanofi Nv
Publication of MA19147A1 publication Critical patent/MA19147A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MA19356A 1980-05-19 1981-05-13 Derives de pyridoxine,leur procede de preparation ainsi que leur utilisation en therapeutique . MA19147A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8016516 1980-05-19

Publications (1)

Publication Number Publication Date
MA19147A1 true MA19147A1 (fr) 1981-12-31

Family

ID=10513518

Family Applications (1)

Application Number Title Priority Date Filing Date
MA19356A MA19147A1 (fr) 1980-05-19 1981-05-13 Derives de pyridoxine,leur procede de preparation ainsi que leur utilisation en therapeutique .

Country Status (32)

Country Link
US (1) US4374841A (enrdf_load_stackoverflow)
EP (1) EP0040591B1 (enrdf_load_stackoverflow)
JP (1) JPS5711966A (enrdf_load_stackoverflow)
AR (1) AR226356A1 (enrdf_load_stackoverflow)
AT (1) ATE3859T1 (enrdf_load_stackoverflow)
AU (1) AU542463B2 (enrdf_load_stackoverflow)
BG (1) BG35327A3 (enrdf_load_stackoverflow)
CA (1) CA1152080A (enrdf_load_stackoverflow)
CS (1) CS223842B2 (enrdf_load_stackoverflow)
DD (1) DD159071A5 (enrdf_load_stackoverflow)
DE (1) DE3160480D1 (enrdf_load_stackoverflow)
DK (1) DK217481A (enrdf_load_stackoverflow)
EG (1) EG15890A (enrdf_load_stackoverflow)
ES (1) ES8203845A1 (enrdf_load_stackoverflow)
FI (1) FI811525A7 (enrdf_load_stackoverflow)
GR (1) GR82343B (enrdf_load_stackoverflow)
HU (1) HU183441B (enrdf_load_stackoverflow)
IE (1) IE51179B1 (enrdf_load_stackoverflow)
IL (1) IL62602A (enrdf_load_stackoverflow)
IN (1) IN151915B (enrdf_load_stackoverflow)
IS (1) IS1183B6 (enrdf_load_stackoverflow)
MA (1) MA19147A1 (enrdf_load_stackoverflow)
NO (1) NO811680L (enrdf_load_stackoverflow)
NZ (1) NZ196766A (enrdf_load_stackoverflow)
OA (1) OA06811A (enrdf_load_stackoverflow)
PL (1) PL129213B1 (enrdf_load_stackoverflow)
PT (1) PT72992B (enrdf_load_stackoverflow)
RO (1) RO81943A (enrdf_load_stackoverflow)
SU (1) SU1077566A3 (enrdf_load_stackoverflow)
YU (1) YU126281A (enrdf_load_stackoverflow)
ZA (1) ZA812448B (enrdf_load_stackoverflow)
ZW (1) ZW9681A1 (enrdf_load_stackoverflow)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663354A (en) * 1984-04-26 1987-05-05 Klinge Pharma Gmbh Use of etilefrin and etilefrin pivalate in the long term treatment of circulatory disorders not due to hypotonia
DE3519693A1 (de) * 1985-06-01 1987-01-02 Basf Ag Pyridin-derivate, ihre herstellung und verwendung
US6051587A (en) * 1998-04-16 2000-04-18 Medicure, Inc. Treatment of iatrogenic and age-related hypertension and pharmaceutical compositions useful therein
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
US6339085B1 (en) 1999-03-08 2002-01-15 The University Of Manitoba Therapeutics for cardiovascular and related diseases
EP1196171A2 (en) * 1999-07-13 2002-04-17 Medicure Inc. Use of pyridoxin derivatives for the treatment of diabetes and related complications
US6677356B1 (en) * 1999-08-24 2004-01-13 Medicure International Inc. Treatment of cardiovascular and related pathologies
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
US6605612B2 (en) 2000-02-29 2003-08-12 Medicure International Inc. Cardioprotective phosohonates and malonates
EP1278526A2 (en) 2000-03-28 2003-01-29 Medicure International Inc. Treatment of cerebrovascular disease
EP1299358B1 (en) 2000-07-07 2007-06-13 Medicure International Inc. Pyridoxine and pyridoxal analogues as cardiovascular therapeutics
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US20040121988A1 (en) * 2001-03-28 2004-06-24 Medicure International Inc. Treatment of cerebrovascular disease
JP4048166B2 (ja) * 2002-11-18 2008-02-13 三井製糖株式会社 血糖値上昇抑制剤及び体脂肪蓄積抑制剤並びに食用材料
US20040186077A1 (en) * 2003-03-17 2004-09-23 Medicure International Inc. Novel heteroaryl phosphonates as cardioprotective agents
CA2520422A1 (en) * 2003-03-27 2004-10-07 Medicure Inc. Compositions for treating angina
US20060019929A1 (en) * 2004-07-07 2006-01-26 Albert Friesen Combination therapies employing platelet aggregation drugs
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
AU2005304220A1 (en) * 2004-10-28 2006-05-18 Medicure International Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
US7459468B2 (en) * 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
US20060094749A1 (en) * 2004-10-28 2006-05-04 Medicure International Inc. Substituted pyridoxines as anti-platelet agents
JP2009517411A (ja) * 2005-11-28 2009-04-30 メディキュア インターナショナル インコーポレーテッド 心血管及び関連病状の処置のための調剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115575A (en) * 1973-02-20 1978-09-19 Ciba-Geigy Corporation 2-(3-Amino-2-hydroxy-propoxy)-pyrazines
AR207133A1 (es) * 1973-02-20 1976-09-15 Ciba Geigy Ag Procedimiento para la elaboracion de derivados de 1-piridiloxi 1-pirimidiniloxi y 1-piraziniloxi-2-hidroxi-3-amino-propano
GB1485919A (en) * 1975-08-12 1977-09-14 Grindstedvaerket As Pyridine derivatives
DE2711655A1 (de) * 1977-03-17 1978-09-21 Basf Ag Pyridinyl-aminoalkylaether
US4210653A (en) * 1978-06-27 1980-07-01 Merck & Co., Inc. Pyridyloxypropanolamines

Also Published As

Publication number Publication date
FI811525L (fi) 1981-11-20
GR82343B (enrdf_load_stackoverflow) 1984-12-13
YU126281A (en) 1984-02-29
ZW9681A1 (en) 1982-01-20
SU1077566A3 (ru) 1984-02-29
PL231193A1 (enrdf_load_stackoverflow) 1982-07-05
RO81943B (ro) 1983-05-30
BG35327A3 (bg) 1984-03-15
CA1152080A (en) 1983-08-16
AU542463B2 (en) 1985-02-21
OA06811A (fr) 1982-12-31
IE811085L (en) 1981-11-19
ES502276A0 (es) 1982-04-01
AR226356A1 (es) 1982-06-30
US4374841A (en) 1983-02-22
RO81943A (ro) 1983-06-01
ATE3859T1 (de) 1983-07-15
JPS5711966A (en) 1982-01-21
EP0040591B1 (fr) 1983-06-22
PL129213B1 (en) 1984-04-30
IS1183B6 (is) 1985-05-13
HU183441B (en) 1984-05-28
PT72992A (en) 1981-06-01
DK217481A (da) 1981-11-20
NZ196766A (en) 1984-02-03
NO811680L (no) 1981-11-20
ES8203845A1 (es) 1982-04-01
IL62602A0 (en) 1981-06-29
ZA812448B (en) 1982-04-28
EG15890A (en) 1987-03-30
PT72992B (en) 1982-07-01
IE51179B1 (en) 1986-10-29
AU7053581A (en) 1981-11-26
IL62602A (en) 1984-06-29
EP0040591A1 (fr) 1981-11-25
FI811525A7 (fi) 1981-11-20
DD159071A5 (de) 1983-02-16
DE3160480D1 (en) 1983-07-28
IS2631A7 (is) 1981-11-11
IN151915B (enrdf_load_stackoverflow) 1983-09-03
CS223842B2 (en) 1983-11-25

Similar Documents

Publication Publication Date Title
MA19147A1 (fr) Derives de pyridoxine,leur procede de preparation ainsi que leur utilisation en therapeutique .
IT8125722A0 (it) Derivati amminoalchil-eterociclici, loro procedimento di preparazione eloro applicazione in terapia.
ZA817675B (en) New nor-tropane and granatane derivatives,the process for preparing the same and their application in therapeutics
BE878548A (fr) Nouveaux derives de tetrazolylalcoxycarbostyrile, procede pour leur preparation et leurs applications en therapeutique
FR2495613B1 (fr) Derives 1-sulfo-2-oxoazetidine, leur procede de preparation et leur utilisation dans des compositions antimicrobiennes
BE892758A (fr) Derives phenylcyclobutyliques, leur procede de preparation et leur application therapeutique
FR2504920B1 (fr) Derives phenylcyclobutyliques, leur procede de preparation et leur application therapeutique
BE890159A (fr) Polyols modifies, leur procede de preparation et leur utilisation
BE890157A (fr) Amino-polyols modifies, leur procede de preparation et leur utilisation
ZA813567B (en) Novel n-aryl azolone derivatives,the process for preparing the same and their application in therapeutics
FI842459A7 (fi) Tetrahydropyridatsinonijohdannaisia, menetelmiä niiden valmistamiseksi sekä niiden käyttö.
FR2348907A1 (fr) Derives polyprenyliques,leur procede de preparation et leur application en therapeutique
FI823022A7 (fi) Amino-organoaminosilaanit, niiden valmistusmenetelmä ja niiden käyttö.
BE884286A (fr) Acylurees, leur procede de preparation et leur utilisation
BE863402A (fr) Azacycloalcanes, azacycloalcenes et derives de ceux-ci, leur procede de preparation et leur application en therapeutique
FR2352783A1 (fr) Derives polyprenyl-carboxyliques, leur procede de preparation et leur application en therapeutique
BE884602R (fr) Nouvelles cinnamoyles piperazines et homopiperazines leur procede de preparation et leur application en therapeutique
LU79266A1 (fr) Triazinones,leur procede de preparation et leur application en therapeutique
FI800350A7 (fi) Dehydropeptidejä, menetelmiä niiden valmistamiseksi sekä niiden käyttö lääkeaineina.
IT8224306A0 (it) Derivati benzilidenici, loro preparazione e loro applicazione in terapia.
BE890612A (fr) Alkyl-3-aryl-3-acyl-2-methyl-carbazates, leur procede de preparation et leur utilisation fongicide
IT8123488A0 (it) Metaboliti, loro preparazione eloro impiego in terapeutica.
BE864111A (fr) Pyrazolo-oxazepines et pyrazolo-thiazepines, leur procede de preparation et leurs applications en therapeutique
FI823200A7 (fi) N-sulfenyloidut bentsyylisulfonamidit, menetelmä niiden valmistamiseksi ja niiden käyttö mikrobisideina.
BE890390A (fr) Derives de prostacycline, leur procede de preparation et leur utilisation